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Abstract. A kinetic study of the tumor-associated galactopyranosyl-(1→3)-2-acetamido-2-deoxy-α-D-
galactopyranoside (T-antigen) with lectin peanut agglutinin is described. The disaccharide antigen was 
synthesized by chemical methods and was functionalized suitably for immobilization onto a carboxy-
methylated sensor chip. The ligand immobilized surface was allowed interaction with the lectin peanut 
agglutinin, which acted as the analyte and the interaction was studied by the surface plasmon resonance 
method. The ligand–lectin interaction was characterized by the kinetic on-off rates and a bivalent analyte 
binding model was found to describe the observed kinetic constants. It was identified that the antigen–
lectin interaction had a faster association rate constant (ka1) and a slower dissociation rate constant (kd1) 
in the initial binding step. The subsequent binding step showed much reduced kinetic rates. The antigen–
lectin interaction was compared with the kinetic rates of the interaction of a galactopyranosyl-(1→4)-β-
D-galactopyranoside derivative and a mannopyranoside derivative with the lectin. 
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1. Introduction 
Cell surface bound carbohydrates are critical in order 
to initiate several cellular recognition events.1 Under-
standing intricate carbohydrate mediated recognition 
events has implications, for example, in the deve-
lopment of carbohydrate based diagnostics and 
therapeutics.2 Important classes of carbohydrates are 
the so-called TN, T and STN antigens and these are 
known to be tumor-associated antigens, resulting 
from drastic changes in the cell surface bound car-
bohydrates.3,4 The T-antigen, namely, the disaccha-
ride galactopyranosyl-(1→3)-2-acetamido-2-deoxy-
α-D-galactopyranoside, is a cancer-related marker 
and is a sustained target for the development of can-
cer vaccines.5 Lectins, the carbohydrate binding pro-
teins, often serve as important tools to analyse 
interactions and specificities of sugar ligands at the 
molecular level.6 The lectin binding studies were 
conducted previously with T-antigen,7,8 involving 
the antigen specific lectin peanut agglutinin (PNA), 
which is a tetrameric protein, at physiological pH, 
having one binding site in each monomer.9 The
specificity and higher binding affinity of the T-antigen 
to the lectin originates through water-mediated hydro-
gen bonding between the acetamido moiety of the 
ligand and the amino acid residues of the lectin.8 In 
our efforts on the kinetic studies of the ligand–lectin 
interactions,10 a kinetic analysis of a synthetic T-
antigen derivative–lectin interaction was undertaken. 
The analysis was performed with the aid of the sur-
face plasmon resonance (SPR) technique, which 
provides information in real-time about the extent of 
an analyte binding to a ligand immobilized onto a 
surface. Interaction of glycopolypeptides carrying the 
T-antigen with PNA and other lectins was reported 
previously by Usui and co-workers, wherein, the 
lectins were immobilized on the surface and the 
polymeric ligands were used as the analyte.11 The 
SPR studies undertaken in the present invesigation 
on immobilized T-antigen–PNA interaction show 
that the association rate constant (ka1) is significantly 
higher in the initial binding step than the subsequent 
binding step. The kinetic constants were compared 
to another lectin specific ligand, namely, galactopyra-
nosyl-(1→4)-β-D-galactopyranoside (lactose) deriva-
tive and a non-specific mannopyranoside derivative. 
Details of synthesis and the binding studies are pre-
sented here. 
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2. Experimental 
2.1 General methods 
Chemicals were purchased from commercial sources 
and were used without further purifications. Sol-
vents were dried and distilled according to literature 
procedures. Analytical TLC was performed on 
commercial plates coated with silica gel GF254 
(0⋅25 mm). Silica gel (100–200 mesh) was used for 
column chromatography. High-resolution mass spec-
tra were obtained from a Q-TOF instrument by an 
electrospray ionization (ESI) technique. 1H and 13C 
NMR spectral analyses were performed on a spec-
trometer operating at 300 and 75 MHz, respectively, 
and the residual solvent signal was used as the inter-
nal standard. The following abbreviations were used 
to explain the multiplicities: s, singlet; d, doublet; t, 
triplet; dd, doublet of doublets; m, multiplet; band, 
several overlapping signals and br, broad. Millipore 
water (Milli Q-plus system, R > 18 mΩ, pH 5⋅5) was 
used to prepare the buffer solution. The buffer solu-
tion consisted of HEPES (10 mM), NaCl (150 mM) 
and the pH was adjusted to 7⋅4. Lectin PNA (salt-
free lyophilized powder) was purchased from Sigma. 
SPR experiments were carried out on a Biacore 
2000, with research grade CM5 sensor chip. 
2.2 N-(Benzyloxycarbonyl)aminoethyl-3,4,6-tri-O-
acetyl-2-azido-2-deoxy-α-D-galactopyranoside (9) 
To a stirring suspension of protected amino alcohol 
8 (0⋅170 g, 0⋅87 mmol), Ag2CO3 (0⋅33 g, 1⋅2 mmol), 
molecular sieves (4 Å) (0⋅10 g) and AgClO4 (0⋅024 g, 
0⋅12 mmol) in CH2Cl2/PhMe (1
 : 1, 15 mL), a solution 
of bromide 713 (0⋅24 g, 0⋅6 mmol) in CH2Cl2/ 
PhMe (1 : 1, 10 mL) was added, under argon atmos-
phere and the reaction mixture was protected from 
light. After 12 h, the reaction mixture was diluted 
with CH2Cl2 (100 mL), filtered over celite and con-
centrated in vacuo. Purification (SiO2, Pet. Ether/ 
EtOAc = 3/2) of the crude residue afforded the re-
quired α-isomer 9 (0⋅19 g, 61%), as a colourless vis-
cous syrup. TLC: Rf 0⋅53 (Pet. Ether/EtOAc = 3
 : 7). 
[α]D
23 + 71⋅0 (c 2⋅0, CHCl3); 
1H NMR (300 MHz, 
CDCl3) δ 7⋅31 (app. s, 5H), 5⋅42 (d, 1H, J = 2⋅3 Hz), 
5⋅35–5⋅33 (m, 2H), 5⋅11 (s, 2H), 5⋅00 (d, 1H, 
J = 3⋅3 Hz), 4⋅22 (t, 1H, J = 6⋅6 Hz), 4⋅07 (app. d, 
2H), 3⋅81 (m, 1H), 3⋅66 (dd, 2H, J = 3⋅6 Hz, 11⋅1 Hz), 
3⋅45 (m, 2H), 2⋅14 (s, 3H), 2⋅05 (s, 3H), 2⋅02 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 170⋅5, 170⋅1, 
169⋅9, 156⋅4, 136⋅4, 128⋅5, 128⋅1, 128⋅0, 127⋅9, 
98⋅4, 68⋅2, 68⋅0, 67⋅5, 66⋅8, 66⋅7, 61⋅7, 57⋅5, 40⋅7, 
20⋅6; HR-MS: calcd. for C22H28N4O10 m/z: 531⋅1703 
[M + Na]+; found: 531⋅1728 [M + Na]+, 547⋅1473 
[M + K]+. 
2.3 N-(Benzyloxycarbonyl)aminoethyl-3,4,6-tri-O-
acetyl-2-acetamido-2-deoxy-α-D-galactopyranoside 
(10) 
A solution of 9 (0⋅09 g, 0⋅176 mmol) in AcSH 
(1 mL) and pyridine (0⋅5 mL) was stirred at room 
temperature for 20 h. Removal of the solvent in 
vacuo followed by purification (PhMe/EtOAc) of 
the residue afforded 10 (0⋅083 g, 90%). TLC: Rf 
0⋅28 (Pet. Ether/EtOAc = 3 : 7). [α]D
23 + 50⋅5 (c 2⋅0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7⋅42–7⋅32 
(m, 5H), 6⋅08 (d, 1H), 5⋅37 (d, 1H, J = 2⋅8 Hz), 
5⋅26–5⋅21 (m, 1H), 5⋅16 (d, 1H, J = 3⋅2 Hz), 5⋅12 (s, 
2H), 4⋅90 (d, 1H, J = 3⋅6 Hz), 4⋅60 (m, 1H), 4⋅18 (t, 
1H), 4⋅09 (app. d, 2H), 3⋅79–3⋅74 (m, 1H), 3⋅63–
3⋅56 (m, 1H), 3⋅47–3⋅41 (m, 1H), 3⋅41–3⋅33 (m, 1H), 
2⋅18 (s, 3H), 2⋅03 (s, 3H), 2⋅02 (s, 3H), 1⋅97 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 170⋅9, 170⋅5, 170⋅3, 
156⋅7, 136⋅2, 128⋅6, 128⋅3, 128⋅2, 98⋅3, 68⋅4, 68⋅3, 
67⋅3, 67⋅0, 66⋅9, 62⋅0, 47⋅6, 40⋅9, 23⋅1, 20⋅8, 20⋅7, 
20⋅6; HR-MS: calcd. for C24H32N2O11 m/z: 547⋅1904 
[M + Na]+; found: 547⋅1914 [M + Na]+. 
2.4 N-(Benzyloxycarbonyl)aminoethyl-4,6-
benzylidene-2-acetamido-2-deoxy-α-D-
galactopyranoside (11) 
A suspension of 10 (0⋅25 g, 0⋅47 mmol) in MeOH 
(10 mL) was stirred in the presence of NaOMe 
(0⋅5 N) (0⋅5 mL). After 3 h, Amberlite IR-120 (H+) 
resin was added to the reaction mixture, filtered and 
solvent evaporated in vacuo to afford the de-O-
acetylated intermediate, as a white solid (0⋅18 g). 
The intermediate was stirred with benzaldehyde di-
methyl acetal (0⋅2 mL) in the presence of p-toluene 
sulphonic acid (0⋅015 g) in DMF (3 mL) at 50°C for 
2 h. The reaction mixture was added with Et3N 
(0⋅010 mL), solvents removed in vacuo and the re-
sulting crude product purified (EtOAc/MeOH = 
1 : 0⋅05) to afford 11 (0⋅19 g, 83%), as a white solid. 
TLC: Rf 0⋅10 (EtOAc). [α]D
23 + 65⋅0 (c 1⋅0, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7⋅53–7⋅49 (m, 5H), 
7⋅37–7⋅30 (app. s, 5H), 6⋅56 (d, 1H, J = 7⋅5 Hz), 
5⋅52 (s, 1H), 5⋅29 (m, 1H), 5⋅11 (q, 2H), 4⋅94 (d, 1H, 
J = 3⋅3 Hz), 4⋅40 (ddd, 1H, J = 3⋅6 Hz, 8⋅7 Hz, 
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11⋅1 Hz), 4⋅21 (d, 1H, J = 12⋅6 Hz), 4⋅09 (d, 1H, 
J = 2⋅7 Hz), 3⋅98 (d, 1H, J = 11⋅8 Hz), 3⋅81 (m, 1H), 
3⋅71 (m, 1H), 3⋅59 (s, 1H), 3⋅42 (m, 2H), 3⋅30 (m, 
2H), 2⋅00 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 172⋅1, 156⋅9, 137⋅5, 136⋅3, 129⋅2, 128⋅6, 128⋅3, 
128⋅2, 128⋅1, 126⋅3, 101⋅2, 98⋅6, 75⋅5, 69⋅0, 67⋅9, 
66⋅9, 63⋅1, 50⋅2, 40⋅8, 23⋅1; HR-MS: calcd. for 
C25H30N2O8 m/z: 509⋅1900 [M + Na]
+; found: 
509⋅1889 [M + Na]+. 
2.5 Aminoethyl-β-D-galactopyranosyl-(1→3)-2-
acetamido-2-deoxy-α-D-galactopyranoside  
(T-antigen derivative) (1) 
A solution of 11 (0⋅103 g, 0⋅212 mmol) in PhMe/ 
MeNO2 (1
 : 1, 8 mL) was stirred for 1 h at room 
temperature and in the absence of light. After re-
moval of approximately half of the solvent in vacuo, 
2,3,4,6-tetra-O-benzoyl-α-D-galctopyranosyl bro-
mide15 (0⋅31 g, 0⋅47 mmol) and Hg(CN)2 (0⋅12 g, 
0⋅47 mmol) were added under argon atmosphere and 
stirred for 20 h. The reaction mixture was diluted 
with EtOAc (20 mL), washed with aq. KI (1 N), fol-
lowed by brine. The organic layer was dried 
(Na2SO4), concentrated in vacuo and purified 
(EtOAc/PhMe = 7 : 3) to afford protected derivative 
of the disaccharide 1 (0⋅20 g, 87%). TLC: Rf 0⋅23 
(Pet. Ether/EtOAc = 2/3). [α]D
23 + 96⋅5 (c 2⋅0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 8⋅04 (d, 2H, 
J = 8⋅4 Hz), 7⋅92 (d, 2H, J = 7⋅3 Hz), 7⋅87 (d, 2H, 
J = 7⋅2 Hz), 7⋅70 (d, 2H, J = 7⋅2 Hz), 7⋅56–7⋅13 
(band, 22H), 5⋅91 (d, 1H, J = 3⋅1 Hz), 5⋅73 (dd, 1H, 
J = 7⋅6 Hz, 10⋅2 Hz), 5⋅66 (d, 1H, J = 9⋅5 Hz), 5⋅52 
(dd, 1H, J = 3⋅2 Hz, 10⋅2 Hz), 5⋅32 (s, 1H), 5⋅08–
4⋅96 (band, 5H), 4⋅66 (m, 1H), 4⋅46 (ddd, 1H, 
J = 3⋅4, 7⋅2, 10⋅9 Hz), 4⋅33 (m, 3H), 4⋅04 (m, 2H), 
3⋅65 (m, 2H), 3⋅44–3⋅22 (band, 4H), 1⋅63 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 170⋅3, 166⋅1, 165⋅6, 
165⋅5, 165⋅1, 156⋅5, 137⋅5, 136⋅4, 135⋅8, 130⋅0–
126⋅0, 101⋅8, 100⋅8, 98⋅5, 75⋅5, 75⋅3, 71⋅8, 71⋅7, 
70⋅2, 69⋅2, 68⋅1, 67⋅9, 66⋅8, 63⋅1, 48⋅5, 40⋅8, 23⋅2; 
HR-MS: calcd. for C59H56N2O17 m/z: 1087⋅3477 
[M + Na]+; found: 1087⋅3622 [M + Na]+, 1103⋅3363 
[M + K]+. 
 A solution of the above protected disaccharide 
(0⋅24 g, 0⋅23 mmol) and CSA (0⋅05 g) in MeOH 
(10 mL) were stirred for 2 h and Et3N (100 μl) was 
added to neutralize CSA and solvents removed. Puri-
fication of the crude product (EtOAc/Pet. Ether = 7 : 3) 
afforded 4,6-de-O-benzylidenated product (0⋅21 g, 
96%), as a gummy solid. A suspension of the pro-
tected disaccharide obtained above (0⋅20 g, 0⋅2 mmol) 
in MeOH (15 mL) and Pd/C (10%) (0⋅025 g) was 
subjected to hydrogenolysis for 24 h. After filtration 
over celite, the solvents were removed in vacuo to 
afford the benzyloxycarbonyl group deprotected 
product, as a white foamy solid. The product was 
dissolved in MeOH and admixed with NaOMe/ 
MeOH (0⋅5 M, 0⋅1 mL) and left stirring for 12 h, 
neutralized with Amberlite IR-120 resin (H+ form), 
filtered and the filtrate concentrated in vacuo. The 
resulting solid was triturated with EtOAc and dried 
to afford 1 (0⋅09 g, 95%). [α]D
23 + 52⋅3 (c 0⋅6, H2O); 
1H NMR (400 MHz, D2O) δ 4⋅74 (d, 1H, 
J = 3⋅6 Hz), 4⋅23 (d, 1H, J = 7⋅2 Hz), 4⋅05 (d, 1H, 
J = 2⋅8 Hz), 3⋅95 (d, 1H, J = 2⋅8 Hz), 3⋅86–3⋅30 
(band, 10H), 3⋅23–3⋅02 (band, 4H), 1⋅67 (s, 3H); 13C 
NMR (75 MHz, D2O) δ 174⋅6, 101⋅2, 97⋅7, 75⋅6, 
74⋅8, 73⋅3, 71⋅3, 69⋅2, 66⋅9, 65⋅1, 63⋅4, 61⋅8, 49⋅3, 
40⋅1, 22⋅3; HR-MS: calcd. for C16H30N2O11: m/z: 
449⋅1747 [M + Na]+, found: 449⋅1747 [M+Na]+. 
2.6 Aminoethyl-β-D-galactopyranosyl-(1→4)-β-D-
glucopyranoside (lactose derivative) (2) 
To a stirring suspension of protected amino alcohol 
8 (0⋅49 g, 2⋅5 mmol), Hg(CN)2 (0⋅63 g, 2⋅5 mmol), 
HgBr2 (0⋅46 g, 1⋅2 mmol) and molecular sieves 
(4 Å) in CH2Cl2 (30 mL), a solution of benzobromo-
lactose15 (2⋅9 g, 2⋅5 mmol) in CH2Cl2 (5 mL) was 
added drop-wise, over a period of 10 min. The mix-
ture was stirred until TLC analysis (Pet. ether/ 
EtOAc = 3 : 2) showed disappearance of the bromide. 
Work-up and purification (SiO2, Pet. ether/EtOAc = 
3 : 2) of the crude residue afforded the O-benzoyl-
protected 2 (2⋅30 g, 74%), as a colourless viscous 
syrup. TLC: Rf 0⋅48 (Pet. ether/EtOAc = 3
 : 2). 
[α]D
23 + 51⋅0 (c 1⋅0, CHCl3); 
1H NMR (300 MHz, 
CDCl3) δ 8⋅17–7⋅99 (m, 12H), 7⋅83 (d, 2H, 
J = 8⋅1 Hz), 7⋅65–7⋅19 (m, 26H), 5⋅95–5⋅86 (m, 2H), 
5⋅57 (app t, 2H), 5⋅30 (br s, 1H), 5⋅18–4⋅95 (m, 3H), 
4⋅73–4⋅71 (app d, 2H), 4⋅62 (dd, 1H, J = 3⋅9 Hz, 
12⋅0 Hz), 4⋅36 (t, 1H, J = 9⋅3 Hz), 4⋅05 (t, 1H, 
J = 6⋅5 Hz), 3⋅92–3⋅70 (m, 5H), 3⋅38 (m, 2H); 13C 
NMR (75 MHz, CDCl3) δ 169⋅8, 166⋅0, 165⋅5, 
165⋅0, 156⋅4, 137⋅9, 136⋅8, 133⋅5, 130⋅5–128⋅1, 
125⋅5, 101⋅5, 101⋅1, 76⋅1, 73⋅4, 73⋅0, 72⋅1, 71⋅6, 
70⋅3, 69⋅5, 67⋅9, 66⋅6, 62⋅6, 61⋅4, 41⋅0. MALDI-
TOF MS: calcd. for C71H61NO20Na m/z: 1271⋅23 
[M + Na]+, found: 1271⋅4 [M + Na]+. 
 A suspension of O-benzoyl-protected 2 (0⋅72 g, 
0⋅54 mmol) in EtOAc/MeOH (1 : 1, 50 mL) and 
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Pd/C (10%) (0⋅3 g) was subjected to hydrogenolysis 
for 16 h. After filtration over celite, the solvents 
were removed in vacuo. The resulting white foamy 
solid was dissolved in MeOH/THF (1 : 1, 10 mL) 
and admixed with NaOMe/MeOH (0⋅5 M, 1 mL), 
left stirring for 12 h, neutralized with Amberlite IR-
120 resin (H+ form), filtered and the filtrate concen-
trated in vacuo. The resulting solid was triturated 
with EtOAc, Me2CO and dried to afford 2 (0⋅19 g, 
90%), as a gummy solid. [α]D
23 + 39⋅2 (c 1⋅0, H2O); 
1H NMR (300 MHz, D2O) δ 4⋅38 (d, 1H, 
J = 7⋅5 Hz), 4⋅29 (d, 1H, J = 7⋅5 Hz), 3⋅98–3⋅1(band, 
16H); 13C NMR (75 MHz, D2O) δ 103⋅7, 102⋅7, 
78⋅9, 76⋅1, 75⋅0, 73⋅4, 73⋅2, 71⋅7, 69⋅3, 66⋅6, 61⋅8, 
60⋅7, 49⋅7, 40⋅2; HR-MS: calcd. for C14H27NO11 
m/z: 386⋅1662 [M + Na]+, found: 386⋅1666 
[M + Na]+. 
2.7 Aminoethyl-α-D-mannopyranoside (3) 
To a stirring suspension of protected amino alcohol 
8 (0⋅86 g, 4⋅4 mmol), Hg(CN)2 (1⋅11 g, 4⋅4 mmol), 
HgBr2 (0⋅79 g, 2⋅2 mmol) and molecular sieves 
(4 Å) in CH2Cl2 (25 mL), a solution of benzobromo-
mannose15 (3⋅0 g, 4⋅5 mmol) in CH2Cl2 (5 mL) was 
added drop-wise over a period of 10 min. The reac-
tion mixture was stirred until TLC analysis (Pet. 
ether/EtOAc = 3 : 2) showed a complete disappea-
rance of the bromide. Work-up and purification 
(SiO2, Pet. ether/EtOAc = 3
 : 2) of the crude residue 
afforded O-benzoyl-protected 3 (3⋅08 g, 91%), as a 
colourless viscous syrup. TLC: Rf 0⋅62 (Pet. ether/ 
EtOAc = 3/2). [α]D
23 + 72⋅0 (c 2⋅0, CHCl3); 
1H 
NMR (300 MHz, CDCl3) δ 8⋅05 (d, 2H, J = 7⋅5 Hz), 
8⋅01 (d, 2H, J = 7⋅8 Hz), 7⋅93 (d, 2H, J = 7⋅8 Hz), 
7⋅77 (d, 2H, J = 7⋅8 Hz), 7⋅64–7⋅21 (m, 17H), 5⋅98 
(app. d, 1H, J = 3⋅3 Hz), 5⋅75 (dd, 1H, J = 7⋅8 Hz, 
10⋅3 Hz), 5⋅60 (dd, 1H, J = 10⋅3 Hz, 3⋅6 Hz), 5⋅16 
(br s, 1H), 5⋅03 (q, 1H, J = 12⋅3 Hz), 4⋅92 (1/2 AB 
q, 1H, J = 12⋅3 Hz), 4⋅80 (d, 1H, J = 7⋅8 Hz), 4⋅64 
(dd, 1H, J = 6⋅6 Hz, 11⋅4 Hz), 4⋅43 (dd, 1H, 
J = 6⋅0 Hz, 11⋅4 Hz), 4⋅31 (t, 1H, J = 6⋅6 Hz), 3⋅99 
(m, 1H), 3⋅75 (m, 1H), 3⋅41 (m, 2H); 13C NMR 
(75 MHz, CDCl3) δ 165⋅9, 165⋅5, 165⋅4, 136⋅5, 
133⋅6, 133⋅3, 133⋅2, 129⋅9–128⋅0, 101⋅8, 71⋅5, 69⋅8, 
69⋅8, 68⋅0, 65⋅2, 62⋅0, 40⋅8; HR-MS: calcd. for 
C44H39NO12 m/z: 796⋅2370 [M + Na]
+; found: 
796⋅2341 [M + Na]+. 
 A suspension of O-benzoyl-protected 3 (1⋅0 g, 
1⋅3 mmol) in EtOAc/MeOH (1 : 1, 20 mL) and Pd/C 
(10%) (0⋅2 g) was hydrogenolysed for 12 h. After 
filtration over celite, the solvents were removed in 
vacuo to afford a white foamy solid. The foamy 
solid was dissolved in MeOH (20 mL) and admixed 
with NaOMe/MeOH (0⋅5 M) (1 mL), left stirring for 
12 h, neutralized with Amberlite IR-120 resin (H+ 
form), filtered and the filtrate concentrated in vacuo. 
The resulting solid was triturated with EtOAc, 
Me2CO and dried to afford 3 (0⋅26 g, 92%), as a 
gummy solid. [α]D
23 + 33⋅0 (c 1⋅0, MeOH); 1H NMR 
(300 MHz, D2O) δ4⋅75 (br s, 1H), 3⋅85–3⋅5 (band, 
6H), 3⋅23–3⋅02 (band, 4H); 13C NMR (75 MHz, 
D2O) δ 100⋅7, 73⋅7, 72⋅4, 71⋅1, 67⋅4, 64⋅1, 61⋅4, 
39⋅8; HR-MS: calcd. for C8H17NO6 m/z: 246⋅0954 
[M + Na]+, found: 246⋅0938 [M + Na]+. 
2.8 SPR experiments 
2.8a Immobilization of sugar ligands onto CM5 
sensor chip: After equilibration of the CM5 sensor 
surface with HEPES buffer (pH 7⋅4), the surface 
was activated with NHS in H2O (0⋅1 M) and EDC in 
H2O (0⋅1 M).
16 The ligand 1 was injected, at a con-
centration of 2 mg/mL in NaOAc buffer (pH 4⋅3) 
(10 mM), with a flow rate of 5 μl/min. To obtain a 
sufficient amount on the surface, the ligand was in-
jected 4 times and after each injection, a gradual in-
crease in response was observed. After coupling, 
remaining NHS esters were blocked by the addition 
of ethanolamine hydrochloride (1⋅0 M) (pH 8⋅5) for 
3 min. The stability of immobilized ligand surface 
was checked by injection of 10 mM NaOH, buffer 
solution and 10 mM glycine–HCl. In this manner, 
approximately 220 RU of 1 on Fc2, 210 RU of 2 on 
Fc3 and 195 RU of 3 on Fc4 were immobilized co-
valently on the CM5 surface. The surface with man-
nose derivative 3 was used as a reference to the  
T-antigen 1 and lactose 2 immobilized surfaces. 
 
2.8b Kinetic experiments for ligand–PNA inter-
actions: All binding experiments with lectin PNA 
was performed at a flow rate of 20 μl/min using 
HEPES buffer as the eluant. The studies were per-
formed in HEPES buffer (10 mM) (pH 7⋅4) contain-
ing NaCl (150 mM) and at 298 K. Injection times of 
PNA were 300 s, followed by 300 s dissociation 
phase. Regeneration was performed with 30 s pulse 
of HCl (100 mM). For the calculations of the kinetic 
constants, PNA was diluted in HEPES buffer rang-
ing from the concentrations of 1, 2, 4, 8 and 16 μM. 
The PNA was diluted in the running buffer (HEPES, 
pH 7⋅4) to minimize the bulk effects attributable to 
changes in the refractive index of the solution. Each 
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PNA solution was injected into channel 2 (T-antigen 
derivative 1), channel 3 (lactose derivative 2) and 
channel 4 (mannopyranoside derivative 4). The spe-
cific response of the PNA towards 1 or 2 was ob-
tained by subtracting the channel 4 response from 
either channel 2 or channel 3 response, respectively. 
The mass transfer limitations were checked after 
each kinetic experiment and mass transfer effects 
were found to be negligible. Sensorgram analysis of 
each ligand–lectin interactions was performed with 
the BIAevaluation software.18 The sensorgrams were 
fitted to the kinetic models and the kinetic constants 
were derived from the global fit of the data to these 
models. The association rate constant for the second 
step of the interaction (ka2) in the bivalent model 
analysis was obtained in the unconventional unit of 
RU–1s–1. The unit of ka2, 1/RUs is modified to 1/Ms 
by the following expression: ka2 (1/Ms) = ka2 (1/RUs) × 
100 × molecular weight of PNA.19 
3. Results and discussion 
Immobilization of the sugar ligands onto the sensor 
chip was desired, which required accordingly the 
functionalization of the ligands. For immobilization 
onto the carboxymethylated dextran coated sensor 
surface, the sugar ligands were functionalized with 
an amine functionality. Apart from the T-antigen de-
rivative (1), a lactose derivative (2) and a manno-
pyranoside derivative (3) were utilized in the study. 
Figure 1 presents the structures of the sugar ligands, 
tethered with the amine functionality. 
3.1 Synthesis of the ligands 1–3 
Synthesis of derivative 1 was initiated from galac-
topyranose (4), which was transformed to 3,4,6-tri-
O-acetyl galactal (5)12 and subsequently to 3,4,6-tri-
O-acetyl-2-azido-2-deoxy-D-galactopyranosyl nitrate 
6 and the bromide 713 (scheme 1). 
 Glycosylation of the aglycosyl acceptor 8 with the 
bromide 7, in the presence of Ag2CO3/AgClO4 pro-
moters, led to the formation of the glycosylated 
product 9 (scheme 2), with the α-anomer in 61% yield 
and the β-anomer in about 35% yield. 
 The α-anomer 9 was treated with AcSH in pyri-
dine14 to afford the acetamido product 10, which was 
de-O-acetylated and converted to 4, 6-O-benzylide-
nated product 11, having a free hydroxyl group at C-
3. Glycosylation of 11 with benzobromogalactose,15 
in the presence of Hg(II), followed by deprotections 
in sequence of the (i) benzylidene group; (ii) benzy-
loxycarbonyl group and (iii) acetyl groups led to the 
isolation of the T-antigen derivative 1 (scheme 2). 
 The preparation of the lactose derivative 2 and the 
mannopyranosyl derivative 3 were accomplished 
through glycosylation using either benzobromo-
lactose or benzobromomannose15 and protected 
ethanolamine 8, in the presence of Hg(II) promoters. 
Deprotections of the protecting groups led to the
 
 
 
 
Figure 1. Structures of sugar ligands 1–3. 
 
 
 
 
Scheme 1. 
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Scheme 2. 
 
 
Scheme 3. 
 
 
 
formation of the free hydroxyl group containing 2 
and 3 (scheme 3). The newly formed glycosyl deri-
vatives 1–3 were characterized by spectroscopic and 
spectrometric methods. 
3.2 Kinetic studies of the interactions of the  
glycosyl derivatives 1–3 with lectin PNA by the  
SPR method 
The ligand–lectin interaction profiles were moni-
tored with the aid of the SPR technique. The SPR 
method provides real-time monitoring of the com-
plexation process and conducting the kinetic assays 
of the complexation. The responses to adsorption 
and desorption processes that occur are recorded in a 
sensorgram, as a function of time. The subsequent 
use of a simulation software allows fitting the ob-
served data with a kinetic model, thereby allowing 
calculation of the kinetic association (ka) and disso-
ciation (kd) rate constants or the equilibrium con-
stant (K). The method warrants that the limitations 
arising due to mass transport phenomena and non-
specific interactions are diminished, in order to elimi-
nate the artifacts during the analysis. The kinetic 
studies were performed on a BIAcore 2000 system 
(Biacore AB, Uppsala, Sweden), using a carboxy-
methylated dextran coated (CM5) sensor chip. The 
ligands 1–3 were immobilized onto the CM5 chip, 
using N-hydroxysuccinimide (NHS) – N-ethyl-N′-
(3-dimethyl aminopropyl)carbodiimide hydrochlo-
ride (EDC) mediated coupling of the amino group of 
the ligand with the carboxylic acid functionalities on 
the sensor surface.16 A low surface density of the 
ligand immobilization was maintained (~200 RU). 
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The lectin PNA was brought in solution as analyte 
into the flow system and was allowed interaction 
with the immobilized ligands. The flow cell contain-
ing immobilized mannopyranoside ligand served as 
the reference to determine the non-specific binding. 
Figure 2 presents the sensorgrams of the interactions 
of PNA with the immobilized ligands 1–3. A con-
siderably higher response was observed for the T-
antigen 1-PNA interaction, when compared to 2-
PNA interaction. The mannopyranoside ligand 3 did 
not show the response for the lectin, reflecting the 
known non-interacting nature of the ligand to the 
lectin.17 The significantly higher response unit for 
the T-antigen 1-lectin interaction is also in agree-
ment with the solution phase studies.8 
 The kinetic study of the immobilized ligand–
lectin interactions was performed at five concentra-
tions, ranging from 1 μM to 16 μM. The complexa-
tion was followed for 300 s and subsequently, the 
buffer solution, without the analyte, was passed over 
the surface for 300 s to dissociate the complex. 
Upon dissociation of the complex, the ligand immo-
bilized surface was regenerated by using a 60 s 
pulse of HCl (100 mM, pH 2⋅4). Figure 3 presents 
the sensorgrams obtained at five different concentra-
tions for the T-antigen 1-lectin and 2-lectin interac-
tions. A visual inspection of the sensorgrams shows 
that the 1-lectin interaction exhibits a faster associa-
tion and a slower dissociation than that of the 2-
lectin interaction. In order to assess the mass trans-
fer limitations, a fixed concentration of the lectin 
(8 μM) was passed over the T-antigen derivative (1)  
 
 
 
Figure 2. The relative responses obtained for the bind-
ing of PNA to T-antigen derivative 1, lactose derivative 2 
and mannose derivative 3 at a particular PNA concentra-
tion (16 μM). 
immobilized surface, at flow rates of 5, 25 and 
75 mL min–1 and the observed binding profiles were 
found to be independent of the flow rates, thereby 
eliminating the mass transfer effects during the 
ligand–lectin interactions. The binding curves, namely, 
the sensorgrams, obtained for the ligand–lectin in-
teractions were fitted to kinetic models, using the 
BIAevaluation programme18 and the fitting was 
judged from the χ2 values, that denote how closely 
the model fits with the observed data. A kinetic 
model with a low χ2 value (χ2 < 10) is considered to 
provide a good fitting with the observed data. With 
the kinetic models analysed, it was found that the 
bivalent analyte binding model provided the best fit 
with the observed data than other models. With the 
bivalent analyte binding model describing the 
ligand–lectin interaction better, two association and 
dissociation rate constants were obtained for the first 
and second steps of the binding processes, according 
to the equation A + B ↔ AB; AB + B ↔ AB2, where 
A and B denote the lectin and ligand, respectively. 
The results of the kinetic analysis resulting from the 
bivalent analyte binding model are given in table 1. 
The bivalent analyte binding model for the T-
antigen 1-lectin interaction showed that the first as-
sociation rate constant (ka1) was much higher (i.e. 
rapid first association) than the second association 
rate constant (ka2). This indicates faster saturation of 
the lectin binding by the ligand in the initial binding 
step, leading to reduced ligand–lectin complexation 
in the subsequent step. In contrast, the lactose 2-
lectin interaction exhibited an equivalent magnitude 
of the association rate constants for both the steps 
(ka1 and ka2), indicating the importance of a two-step 
process in the binding of the lectin to the immobi-
lized lactose derivative 2. The dissociation rate con-
stants for the first (kd1) and second (kd2) steps 
showed a similar magnitude for both the ligands 1 
and 2. 
 However, considering the association rate con-
stants, it is seen that 1-lectin complex exhibits a 
slower dissociation rate constant for the first step 
than that for the 2-lectin complexation. This trend 
indicates that (i) the T-antigen 1-lectin complexation 
has a rapid association rate constant and a slower 
dissociation rate constant and (ii) the lactose deri-
vative 2 binds to the lectin slowly and subsequently, 
the ligand–lectin complex dissociated relatively faster. 
 The main driving force for the complexation re-
sides in the initial binding event, characterized by ka1 
and kd1, as the initial binding event is far more
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Figure 3. The sensorgrams of the interaction of PNA with (a) T-antigen derivative 1 and (b) lactose 
derivative 2, at PNA concentrations of 1, 2, 4, 8 and 16 μM (bottom to top). The solid lines represent 
the experimental data and dotted lines represent the global fits of the data to a bivalent analyte binding 
model. 
 
 
Table 1. Kinetic data for the binding of PNA to T-antigen 1 and lactose 2 derivatives at 
25°C. 
 Bivalent analyte binding analysis 
 
Sugar ligand ka1 (M
–1 s–1) kd1 (s
–1) ka2 (M
–1 s–1) kd2 (s
–1) χ2 
 
T-antigen (1) 9⋅77 × 102 2⋅32 × 10–2 9⋅74 × 101 1⋅65 × 10–3 2⋅4 
Lactose (2) 1⋅69 × 102 2⋅47 × 10–2 1⋅21 × 102 1⋅86 × 10–3 0⋅8 
 
important than the subsequent binding events. The 
association constants (Ka1), calculated as ka1/kd1, 
were found to be 4⋅2 × 104 M–1 and 6⋅8 × 103 M–1 for 
the T-antigen 1-lectin and lactose derivative 2-lectin 
complexations, respectively. These Ka1 values for 
the immobilized ligand–lectin complexes are slightly 
higher when compared to those known previously 
from the solution phase studies on un-derivatized T-
antigen–PNA and lactose–PNA interactions,8 having 
Ka values of 2⋅4 × 10
4 M–1 and 2⋅0 × 103 M–1, res-
pectively. 
 The important outcome of the kinetic studies pre-
sented here is the identification of the faster associa-
tion rate constant in the initial binding event of the 
T-antigen 1-lectin interaction and the considerably re-
duced association rate constant in the subsequent 
step of the complexation. The faster association rate 
constant (ka1) is also coupled with slower dissociation 
rate constant (ka1). In contrast, the lactose derivative 
2, which is also specific to the lectin PNA, has a 
weaker association rate constant (ka1) in the initial 
binding process and a relatively faster dissociation 
rate constant (kd1). The subsequent binding process 
also has an association rate constant (ka2) of similar 
magnitude as the first binding step, thereby indi-
cating the contributions of both the steps in the 
ligand–lectin interaction. 
4. Conclusion 
In conclusion, synthesis of amine-tethered T-antigen 
disaccharide derivative (1), a lactose derivative (2) 
and a mannopyranoside derivative (3) were accom-
plished and these derivatives were immobilized onto 
a CM5 sensor surface suitable for the kinetic analysis 
of the ligand–lectin binding behaviour. Lectin PNA 
was used to determine the kinetics of the ligand–
lectin complexations. A bivalent analyte binding 
model was found to be suitable to fit the kinetic 
analysis. From the studies, it is identified that the T-
antigen 1-lectin interaction is nearly saturated in the 
initial step of binding (ka1), whereas the lactose  
derivative 2 binds to the lectin with comparable as-
sociation rate constants for both the initial and sub-
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sequent binding steps (ka1 and ka2). The results of the 
present study may bear importance for a better un-
derstanding of the ligand–lectin interactions relevant 
to ligand types that result from acute biological ab-
errations. 
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